| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |